Question follow-through · 92020

Cannabis: Medical Treatments

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support and fund clinical trials aimed at achieving licensing and NHS access for complex, cannabis-based medicines used in the treatment of severe, drug-resis

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
18 Nov 2025
Target answer date
20 Nov 2025
Answer
25 Nov 2025 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 18 Nov 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support and fund clinical trials aimed at achieving licensing and NHS access for complex, cannabis-based medicines used in the treatment of severe, drug-resis

  2. 20 Nov 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 25 Nov 2025

    Answer published

    The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is funding two trials to investigate the safety and efficacy of cannabinoid treatments for drug-resistant epilepsy in both adults and children...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Multiple Sclerosis: Health Services

9 Dec 2025 · To ask the Secretary of State for Health and Social Care, what data his department collects to monitor potential inequalities in multiple sclerosis care access; and how those findings are used to inform policy and service delivery improvements.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Liver Diseases: Health Services

10 Jul 2026 · To ask the Secretary of State for Health and Social Care, what funding has been allocated to the NHS Liver Transformation Programme for 2026-27.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Liver Diseases: Health Services

10 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the NHS Liver Transformation Programme is adequately staffed and prioritised during the ongoing reorganisation of NHS England.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Liver Diseases: Health Services

10 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the NHS Liver Transformation Programme reduces health inequalities in liver disease outcomes for people living in areas with high levels of deprivation.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Drugs: Rare Diseases

28 Aug 2026 · To ask the Secretary of State for Health and Social Care, how treatments for rare conditions will be prioritised for inclusion in the Government’s proposed pilot on supporting faster access to innovative medicines, as part of the UK-US pharmaceutical agre

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Drugs: Rare Diseases

28 Aug 2026 · To ask the Secretary of State for Health and Social Care, further to the UK-US pharmaceutical agreement, how the Government’s proposed pilot on productivity benefits in medicines assessment will account for the wider value of treatments for rare condition

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Drugs: Rare Diseases

28 Aug 2026 · To ask the Secretary of State for Health and Social Care, how patient organisations representing people living with rare conditions will be consulted on the development of new pilots being delivered as part of the UK-US trade agreement.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Liver Diseases: Health Services

7 Sept 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce geographic variation in liver disease (a) diagnosis (b) treatment and (c) health outcomes.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Liver Diseases: Health Services

7 Sept 2026 · To ask the Secretary of State for Health and Social Care, what steps her Department is taking to reduce health inequalities in liver disease outcomes in the North West.